Cargando…

Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy

Nanoparticles have increasingly been used for a variety of applications, most notably for the delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery systems have been developed for cancer treatment and various materials have been explored as drug delivery agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohcharoenkal, Warangkana, Wang, Liying, Chen, Yi Charlie, Rojanasakul, Yon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977416/
https://www.ncbi.nlm.nih.gov/pubmed/24772414
http://dx.doi.org/10.1155/2014/180549
_version_ 1782310414120386560
author Lohcharoenkal, Warangkana
Wang, Liying
Chen, Yi Charlie
Rojanasakul, Yon
author_facet Lohcharoenkal, Warangkana
Wang, Liying
Chen, Yi Charlie
Rojanasakul, Yon
author_sort Lohcharoenkal, Warangkana
collection PubMed
description Nanoparticles have increasingly been used for a variety of applications, most notably for the delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery systems have been developed for cancer treatment and various materials have been explored as drug delivery agents to improve the therapeutic efficacy and safety of anticancer drugs. Natural biomolecules such as proteins are an attractive alternative to synthetic polymers which are commonly used in drug formulations because of their safety. In general, protein nanoparticles offer a number of advantages including biocompatibility and biodegradability. They can be prepared under mild conditions without the use of toxic chemicals or organic solvents. Moreover, due to their defined primary structure, protein-based nanoparticles offer various possibilities for surface modifications including covalent attachment of drugs and targeting ligands. In this paper, we review the most significant advancements in protein nanoparticle technology and their use in drug delivery arena. We then examine the various sources of protein materials that have been used successfully for the construction of protein nanoparticles as well as their methods of preparation. Finally, we discuss the applications of protein nanoparticles in cancer therapy.
format Online
Article
Text
id pubmed-3977416
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39774162014-04-27 Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy Lohcharoenkal, Warangkana Wang, Liying Chen, Yi Charlie Rojanasakul, Yon Biomed Res Int Review Article Nanoparticles have increasingly been used for a variety of applications, most notably for the delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery systems have been developed for cancer treatment and various materials have been explored as drug delivery agents to improve the therapeutic efficacy and safety of anticancer drugs. Natural biomolecules such as proteins are an attractive alternative to synthetic polymers which are commonly used in drug formulations because of their safety. In general, protein nanoparticles offer a number of advantages including biocompatibility and biodegradability. They can be prepared under mild conditions without the use of toxic chemicals or organic solvents. Moreover, due to their defined primary structure, protein-based nanoparticles offer various possibilities for surface modifications including covalent attachment of drugs and targeting ligands. In this paper, we review the most significant advancements in protein nanoparticle technology and their use in drug delivery arena. We then examine the various sources of protein materials that have been used successfully for the construction of protein nanoparticles as well as their methods of preparation. Finally, we discuss the applications of protein nanoparticles in cancer therapy. Hindawi Publishing Corporation 2014 2014-03-20 /pmc/articles/PMC3977416/ /pubmed/24772414 http://dx.doi.org/10.1155/2014/180549 Text en Copyright © 2014 Warangkana Lohcharoenkal et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Lohcharoenkal, Warangkana
Wang, Liying
Chen, Yi Charlie
Rojanasakul, Yon
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
title Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
title_full Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
title_fullStr Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
title_full_unstemmed Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
title_short Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
title_sort protein nanoparticles as drug delivery carriers for cancer therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977416/
https://www.ncbi.nlm.nih.gov/pubmed/24772414
http://dx.doi.org/10.1155/2014/180549
work_keys_str_mv AT lohcharoenkalwarangkana proteinnanoparticlesasdrugdeliverycarriersforcancertherapy
AT wangliying proteinnanoparticlesasdrugdeliverycarriersforcancertherapy
AT chenyicharlie proteinnanoparticlesasdrugdeliverycarriersforcancertherapy
AT rojanasakulyon proteinnanoparticlesasdrugdeliverycarriersforcancertherapy